Stoke Therapeutics
STOK
STOK
133 hedge funds and large institutions have $744M invested in Stoke Therapeutics in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
6% more funds holding
Funds holding: 126 → 133 (+7)
2.85% more ownership
Funds ownership: 117.2% → 120.06% (+2.9%)
95% less call options, than puts
Call options by funds: $35K | Put options by funds: $672K
Holders
133
Holding in Top 10
4
Calls
$35K
Puts
$672K
Top Buyers
| 1 | +$46.2M | |
| 2 | +$8.39M | |
| 3 | +$6.26M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.49M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.72M |
Top Sellers
| 1 | -$34.7M | |
| 2 | -$4.86M | |
| 3 | -$4M | |
| 4 |
Goldman Sachs
New York
|
-$3.42M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.22M |